Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD. [electronic resource]
Producer: 20181102Description: 2-11 p. digitalISSN:- 1096-0007
- Administration, Oral
- Analysis of Variance
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured
- Choroidal Neovascularization -- drug therapy
- Disease Models, Animal
- Humans
- Mice
- Phenylurea Compounds -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Quinolines -- pharmacology
- Vascular Endothelial Growth Factor A -- metabolism
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.